Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02794350
Other study ID # 15/17/181
Secondary ID
Status Recruiting
Phase N/A
First received May 30, 2016
Last updated June 9, 2016
Start date July 2015
Est. completion date December 2025

Study information

Verified date June 2016
Source University Hospital, Antwerp
Contact Paul Van de Heyning, Prof. dr.
Phone 0032 3 821 47 90
Email paul.van.de.heyning@uza.be
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Observational

Clinical Trial Summary

The cognitive profile of older adults with a severe to profound hearing impairment is determined by means of the Repeatable Battery for the Assessment of Neuropsychological Status, adjusted for Hearing impaired subjects (RBANS-H) before and after cochlear implantation. In this prospective, longitudinal study the participants are tested preoperatively, at six months and twelve months postoperatively and from then on yearly up to 10 years after implantation. In addition to the RBANS-H an audiological examination and an semistructured interview is conducted concerning the cochlear implant use and the self-reliance of the patient and subjective questionnaires are filled out by the subjects to assess quality of life and hearing benefit.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 2025
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender Both
Age group 55 Years and older
Eligibility Inclusion Criteria:

- age: 55 or older

- cochlear implant candidate (speech understanding in quiet worse than 60% at 65 decibel sound pressure level (dB SPL) in the best aided condition)

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
Cochlear implant


Locations

Country Name City State
Belgium Antwerp University Hospital Edegem Antwerp

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Antwerp

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary RBANS-H total score The RBANS-H assesses five cognitive domains (Immediate Memory, Visuospatial/constructional, Language, Attention and Delayed Memory). The test consists of twelve subtests and the score on each subtest contributes to one of the five domains. Change from baseline RBANS-H total score at 6 months No
Secondary Best aided speech audiometry in noise: Speech reception threshold (SRT) The speech reception in noise is assessed by means of the Leuven Intelligibility Sentences Test (LIST) using an adaptive procedure. This speech material is developed to quantify the speech understanding in subjects with severely impaired hearing. The frequency spectrum of the noise signal is equal to the long-term average speech spectrum of the sentences. The level of the noise is fixed at 65 dB SPL, while the level of the speech signal is altered depending on the response of the patient. Each list consists of ten sentences and the speech reception threshold (SRT) is calculated as the mean level of the last five sentences together with the level of the imaginary 11th sentence of the list. This speech in noise test is performed both pre- and postoperatively in an aided, free field situation with the loudspeaker in front of the subject at a distance of one meter. Change from baseline best aided SRT at 6 months No
Secondary Nijmegen Cochlear Implant Questionnaire (NCIQ) NCIQ is a self-assessment health-related quality of life instrument developed for use in CI users. The questionnaire consists of sixty questions divided into three principal domains: Physical, Psychological and Social. The first domain comprises three subdomains, namely Basic sound perception, Advanced sound perception and Speech production. The Psychological domain contains the subdomain Self-esteem and the Social domain handles questions about Activity limitations and Social interactions. Each subdomain covers ten statements. Each statement is rated on a 5-point Likert scale ranging from 'Never' to 'Always'. Change from baseline NCIQ score at 6 months No
Secondary RBANS-H index scores The RBANS-H assesses five cognitive domains (Immediate Memory, Visuospatial/constructional, Language, Attention and Delayed Memory). The test consists of twelve subtests and the score on each subtest contributes to one of the five domains. Change from baseline RBANS-H index scores at 6 months No
Secondary Hearing thresholds: best aided Fletcher Index (FI) The best-aided thresholds with hearing aid(s) and/or cochlear implant (CI) are measured through free field audiometry with warble tones. The loudspeaker is placed at a distance of one meter in front of the subject at ear level. Change from baseline best aided FI at 6 months No
Secondary Speech audiometry in quiet (phoneme score): score at 65 dB SPL Speech reception in quiet is measured using Dutch open-set word lists. Each list consists of twelve monosyllabic words (consonant-vowel-consonant) of which one is a training item. One list is presented at 65 dB SPL in free field (aided, pre- and postoperatively) with a loudspeaker at 0° azimuth. The speech recognition score is the percentage of correctly identified phonemes. Change from baseline score at 65 dB SPL at 6 months No
Secondary Speech, Spatial and Qualities of Hearing scale 12 (SSQ12) The SSQ12 is a short form of the Speech, Spatial and Qualities of Hearing scale. It is developed for use in clinical research and rehabilitation settings to measure a range of hearing disabilities across several domains such as speech in noise, speech in speech, localization, distance and movement, segregation and listening effort. The twelve items of this questionnaire are rated on a visual analog scale from 0 to 10 and the overall score is calculated by taking the average of the scores on these twelve items. Change from baseline SSQ12 score at 6 months No
Secondary Hospital Anxiety and Depression Scale (HADS) To detect states of depression and anxiety the Hospital Anxiety and Depression Scale (HADS) is used. This self-assessment questionnaire consists of seven items in the subscale Depression and seven items in the subscale Anxiety and distinguishes clearly between both emotional disorders. Change from baseline HADS score at 6 months No
Secondary Hearing Implant Sound Quality Index 19 (HISQUI19) The HISQUI19 is a 19-item questionnaire to quantify the degree of self-perceived auditory benefit experienced by CI users in everyday communication situations. The 19 items are rated on a 7-point Likert scale ranging from always (99%) to never (1%). To calculate the overall score the corresponding numerical value of each item (from always = 7 to never = 1) is added. Uncompleted items and the response option 'not applicable' correspond to 0 in this calculation. A total score of less than 30, 30 to 59, 60 to 89, 90 to 109 and 110 to 133 is respectively classified as a very poor, poor, moderate, good and very good self-perceived auditory benefit. The validated Dutch version of the questionnaire is used. Change from baseline HISQUI19 score at 6 months No
See also
  Status Clinical Trial Phase
Completed NCT00013416 - Measurement and Prediction of Outcomes of Amplification Phase 2
Completed NCT00977418 - Brain and Cognitive Changes After Reasoning or Physical Training in Cognitively Normal Seniors N/A
Recruiting NCT01620385 - Cochlear Implant PDA Based Research Platform Phase 1
Completed NCT00037986 - Functioning, Disability, and Quality of Life in the Adult Hearing Impaired Phase 2
Completed NCT01837550 - Educational Program for Hearing Aid Users With Internet Support N/A
Completed NCT00013364 - Effects of Stimulus Validity on Speech Recognition Phase 2